Projects
Thanks to our incredible supporters, we fund innovative and ground-breaking medical research towards finding new treatments and cures for Bone Marrow Failure Syndromes and improving patient outcomes
Discovering new genes and mutations that cause failure of bone marrow neutrophil production.
2018-2020 (Grant in aid): Discovering new genes and mutations that cause failure of bone marrow neutrophil production. Professor Graham Lieschke, Australian Regenerative Medicine Institute/Monash University and The Royal Melbourne Hospital. ...
Read moreUsing induced pluripotent stem cells to find causes and cures for bone marrow failure in children and young adults.
2018-2020 (Grant in aid): Using induced pluripotent stem cells to find causes and cures for bone marrow failure in children and young adults. Professor Andrew Elefanty, Murdoch Children’s Research Institute. The work of Professor ...
Read moreIdentifying therapeutics which can be repurposed for the treatment of Myelodysplastic Syndromes and other Bone Marrow Failure Disorders.
2018-2020 (Grant in aid ): Identifying therapeutics which can be repurposed for the treatment of Myelodysplastic Syndromes and other Bone Marrow Failure Disorders. Dr Amee George, The Australian National University. Dr Amee George is situated at ...
Read moreBone Marrow Failure Syndromes in Australia: improving diagnosis to inform strategies for better care and outcomes.
2019-2020 (Doctoral Degree Fellowship): Bone Marrow Failure Syndromes in Australia: improving diagnosis to inform strategies for better care and outcomes. Dr Lucy Fox, The University of Melbourne. Dr Lucy Fox is completing a higher degree ...
Read moreInfluences of clonal haematopoiesis in allogeneic bone marrow transplantation.
2018-2020 (Grant in aid): Influences of clonal haematopoiesis in allogeneic bone marrow transplantation. Dr Paul Yeh and Professor Mark Dawson, The University of Melbourne. Dr Paul Yeh’s research focusses on using genetic testing to study clonal ...
Read morePredicting malignant transformation of bone marrow failure syndromes using longitudinal targeted sequencing of peripheral blood and cell-free DNA (cfDNA).
2017-2019 (Grant): Predicting malignant transformation of bone marrow failure syndromes using longitudinal targeted sequencing of peripheral blood and cell-free DNA (cfDNA). Dr Piers Blombery, Peter MacCallum Cancer Centre. Dr Piers Blombery is ...
Read moreGenome editing of haematopoietic stem and progenitor cells to uncover novel therapeutics for aplastic anaemia and other bone marrow failure syndromes.
2017-2020 (Fellowship): Genome editing of haematopoietic stem and progenitor cells to uncover novel therapeutics for aplastic anaemia and other bone marrow failure syndromes. Dr Yih-Chih Chan and Professor Mark Dawson, The University of ...
Read moreIdentification of miRNA biomarkers which play a functional role in disease pathogenesis and are predictive of inferior outcomes in AA/MDS.
2016-2018 (Grant-in-aid): Identification of miRNA biomarkers which play a functional role in disease pathogenesis and are predictive of inferior outcomes in AA/MDS. Dr Lynette Chee, The Royal Melbourne Hospital/Melbourne Health. Dr Lynette ...
Read morePrevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders. (Part 2)
2017-2019 (Grant): Part 2 – Prevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders. Dr Wayne Crismani, St Vincent’s Institute of Medical Research. Dr Wayne Crismani from the St ...
Read morePrevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders (Part 1).
2016-2019 (Fellowship): Part 1 – Prevention and treatment of bone marrow failure in Fanconi anaemia and other inherited disorders. Dr Wayne Crismani, St Vincent’s Institute of Medical Research. Dr Wayne Crismani from the St Vincent’s ...
Read moreThe Australian Aplastic Anaemia Registry as a Means for Advancing Effective Treatment of Aplastic Anaemia.
2015-2018: The Australian Aplastic Anaemia Registry as a Means for Advancing Effective Treatment of Aplastic Anaemia. Monash University, on behalf of the Aplastic Anaemia Registry (AAR) – an initiative of the Transfusion Outcomes ...
Read more